Physician profile
Patrick Dauphin
NPI 1962866004
$9,120.17
in general payments reported to CMS, 2019-2025
35 companies · $488 in 2025
The $488 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $738 · 2020: $607 · 2021: $1,387 · 2022: $657 · 2023: $2,007 · 2024: $3,235 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,714 · Travel and Lodging: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,714.33 |
| Travel and Lodging | $1,016.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,362.25 | 2021-2025 | Turbohawk, Micra, Hawkone |
| Abiomed | $1,107.64 | 2023-2025 | Impella |
| Astrazeneca Pharmaceuticals Lp | $863.64 | 2019-2024 | Wainua |
| Boston Scientific Corporation | $661.63 | 2021-2024 | Watchman Access System, Rhythmia Mapping System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $644.85 | 2019-2024 | Jardiance |
| Penumbra, INC. | $575.01 | 2023-2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $479.23 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $427.78 | 2019-2025 | Lifevest |
| Pfizer INC. | $423.71 | 2019-2024 | |
| Philips North America LLC | $311.18 | 2023-2024 | (Bh4) Igt Devices Undivided, (6571) Eagle Eye |
| Novartis Pharmaceuticals Corporation | $269.79 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $212.07 | 2021-2024 | Xarelto |
| Shockwave Medical, INC | $205.84 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $184.35 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $179.04 | 2021-2025 | Camzyos, Eliquis |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $153.23 | 2023 | Lifesparc, Tandemlife |
| Acist Medical Systems, INC. | $149.44 | 2023 | |
| Cvrx, INC. | $145.58 | 2024 | Barostim Neo System |
| Amgen INC. | $133.07 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $131.38 | 2019 | |
| Scpharmaceuticals INC. | $105.87 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $64.30 | 2020-2022 | |
| Irhythm Technologies, INC. | $47.61 | 2019-2022 | |
| Astellas Pharma US INC | $43.05 | 2019-2020 | |
| Imperative Care, INC | $38.19 | 2025 | Symphony Catheter |
| Chiesi USA, INC. | $31.03 | 2023-2025 | Cleviprex, Kengreal |
| Akcea Therapeutics, INC. | $28.63 | 2019 | |
| Cardiva Medical, INC. | $24.76 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.45 | 2021 | |
| Biosense Webster, INC. | $19.21 | 2025 | Carto 3 |
| Stryker Corporation | $16.09 | 2025 | Artix Mt |
| Ge Healthcare | $15.78 | 2025 | |
| Cardiovascular Systems INC. | $15.08 | 2021 | |
| Edwards Lifesciences Corporation | $13.93 | 2024 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dauphin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.